Some post-surgical patients at a Denver hospital were left hurting when a case management coordinator quietly traded out their prescribed opioid pills for over-the-counter meds, according to federal prosecutors.
In federal court in Denver on Thursday, former Intermountain Health case management coordinator Shelbi Wolken, 35, of Wheat Ridge, admitted she carried out the pill swaps using patient records and in-hospital pharmacy pickups. Prosecutors say her actions left some patients in serious pain after surgery.
According to a press release from the U.S. Attorney’s Office, District of Colorado, Wolken pleaded guilty to one count of tampering with a consumer product. Investigators say she used her access as a case management coordinator to collect an oxycodone prescription at the in-house pharmacy at Saint Joseph’s Hospital, then brought the bottle back filled with loratadine and other over-the-counter medications instead of the painkillers that had been prescribed.
Federal investigators reported that between December 2023 and July 2024, Wolken picked up roughly 139 prescriptions meant for about 127 different patients. Several of those patients later reported significant pain and complications following surgery.
State regulators and hospital response
Regulators and hospital officials had already raised red flags about medication handling before the federal criminal case landed in court, according to state records and local coverage.
The Colorado Springs Gazette reported that the Colorado State Board of Nursing first issued an emergency suspension, then revoked Wolken’s nurse aide certification after internal monitoring surfaced suspicious pharmacy pickup activity. Intermountain told the paper that when it suspects staff of diverting drugs, it notifies law enforcement and pulls employees from duty while investigations play out. Those early findings triggered broader internal reviews at Saint Joseph’s and other Intermountain facilities, according to the Gazette.
Investigation and courtroom timeline
Wolken appeared before U.S. District Judge Nina Y. Wang, who scheduled sentencing for June 10, 2026. The U.S. Attorney’s Office, District of Colorado, said the case was investigated by the Food and Drug Administration’s Office of Criminal Investigation and the Drug Enforcement Administration. Assistant U.S. Attorney Bryan Fields is prosecuting the case, which is filed as Case No. 26-cr-00023-NYW.
Why diversion matters
When hospital staff tamper with prescribed medications, patients can end up under-treated, in unnecessary pain, and more likely to suffer complications. Health officials say this kind of diversion also erodes public trust in hospitals and the systems meant to safeguard controlled substances.
Colorado’s struggles with drugs are hardly theoretical. The state recorded a drug overdose death rate of 29.8 per 100,000 people in 2022, according to the CDC, underscoring how tightly controlled substances are supposed to be managed.
Legal implications
Wolken’s guilty plea is for tampering with a consumer product, a federal crime laid out in 18 U.S.C. § 1365, which covers tampering with drugs and other consumer products when done with reckless disregard for the risk of harm.
At the June sentencing hearing, Judge Wang will weigh federal sentencing guidelines alongside the extent of harm to affected patients before deciding how much prison time and other penalties Wolken will face.
